References
Brito-Babapulle F (1997) Clonal eosinophilic disorders and the hypereosinophilic syndrome. Blood Rev 11: 129–145
Chowers Y, Holtmeier W, Morzycka-Wroblewska E, Kagnoff MF (1995) Inverse PCR amplification of rare T cell receptor delta messages from mucosal biopsy specimens. J Immunol Methods 179: 261–263
Fauci AS, Harley JB, Roberts WC, Ferrans VJ, Gralnick HR, Bjornson BH (1982) NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med 97: 78–92
Satoh T, Sun L, Li MS, Spry CJ (1994) Interleukin-5 mRNA levels in blood and bone marrow mononuclear cells from patients with the idiopathic hypereosinophilic syndrome. Immunology 83: 308–312
Schrezenmeier H, Thome SD, Tewald F, Fleischer B, Raghavachar A (1993) Interleukin-5 is the predominant eosinophilopoietin produced by cloned T lymphocytes in hypereosinophilic syndrome. Exp Hematol 21: 358–365
Tamaru Y, Nakashita M, Okumura R, Matsumoto S, Imai T (2003) Spontaneous remission of a massive CNS inflammation with eosinophilic infiltrate. Intern Med 42: 424–427
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Toyabe, Si., Harada, W. & Uchiyama, M. Interleukin-3-producing CD4+ T-cells support eosinophil survival in a patient with transient hypereosinophilia. Eur J Pediatr 162, 889–890 (2003). https://doi.org/10.1007/s00431-003-1325-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-003-1325-5